The East African
Tuesday February 02 2021
Summary
Cipla is negotiating with the Pan-African Trade and Development Bank (TDB) to buy the $12 million Zambia debt.
When concluded, the credit-to-cash deal will give Cipla immediate cash flow, and cushion the company’s profits and the shareholder’s net worth from further erosion.
Advertisement
Ugandan pharmaceutical firm Cipla Quality Chemicals shares have gone up 17.8 percent, to an average of Ush112 (0.030) per unit in the first three weeks of January, from Ush95 ($0.025) in July-August 2020.
Investment advisors attribute the rise of the share price to the drug maker’s remodelling of its business and planned discount of the Zambia debt.